Contemporary outcomes of 2287 patients with bladder cancer who were treated with radical cystectomy: A Canadian multicentre experience

BJU International

Volumn 108, Issue 4, 2011, Pages 539-545

  Yafi, Faysal A ^a   Aprikian, Armen G ^a   Chin, Joseph L ^d   Fradet, Yves ^b   Izawa, Jonathan ^d   Estey, Eric ^f   Fairey, Adrian ^f   Rendon, Ricardo ^g   Cagiannos, Ilias ^e   Lacombe, Louis ^b   Lattouf, Jean Baptiste ^c   Bell, David ^g   Drachenberg, Darrel ^h   Kassouf, Wassim ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITÉ LAVAL   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF ALBERTA   (Canada)

^g DALHOUSIE UNIVERSITY   (Canada)

^h UNIVERSITY OF MANITOBA   (Canada)

Author keywords

bladder cancer; lymphadenectomy; muscle invasive; radical cystectomy; smoking

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ANALYTICAL PARAMETERS; BLADDER CANCER; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTCOME VARIABLE; OVERALL SURVIVAL; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; REVIEW; SMOKING; SURGICAL MORTALITY; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; CANADA; CHEMOTHERAPY, ADJUVANT; CYSTECTOMY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; URINARY DIVERSION;

EID: 79961093793     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09912.x     Document Type: Review

References (32)

1. Madersbacher S, Hochreiter W, Burkhard F, et al,. Radical cystectomy for bladder cancer today- a homogeneous series without neoadjuvant therapy. J Clin Oncol 2003; 4: 690-6 (Pubitemid 46621904)
2. Ghoneim MA, Abdel-Latif M, El-Mekresh M, et al,. Radical cystectomy for carcinoma of the bladder: 2,720 consecutive cases 5 years later. J Urol 2008; 180: 121-7
3. Stein JP, Lieskovsky G, Cote R, et al,. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001; 19: 666-75 (Pubitemid 32120143)
4. Shariat SF, Karakiewicz PI, Palapattu GS, et al,. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. J Urol 2006; 176: 2414-22 (Pubitemid 44755069)
5. Dalbagni G, Genega E, Hashibe M, et al,. Cystectomy for bladder cancer: a contemporary series. J Urol 2001; 165: 1111-6 (Pubitemid 32210214)
6. Kachnic LA, Kaufman DS, Heney NM, Althausen AF, Griffin PP, Zietman AL,. Bladder preservation by combined modality therapy for invasive bladder cancer. J Clin Oncol 1997; 15: 1022-9 (Pubitemid 27106286)
7. Shipley WU, Kaufman DS, Heney NM, Althausen AF, Zietman AL,. An update of selective bladder preservation by combined modality therapy for invasive bladder cancer. Eur Urol 1998; 33: 32-4 (Pubitemid 28230285)
8. World Health Organization (WHO) Consensus Conference on Bladder Cancer, Hautmann R, Abol-Enein H, Hafez K, et al,. Urinary diversion. Urology 2007; 69: 17-49 (Pubitemid 46186479)
9. Kessler T,. Attempted nerve-sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic substitution. J Urol 2004; 172: 1323-7 (Pubitemid 39249707)
10. Vieweg J, Gschwend JE, Herr HW, et al,. The impact of primary stage on survival in patients with lymph node positive bladder cancer. J Urol 1999; 161: 72-6 (Pubitemid 29422294)
11. Leissner J, Hohenfellner R, Thuroff JW, Wolf HK,. Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. BJU Int 2000; 85: 817-23 (Pubitemid 30242784)
12. Lerner SP, Skinner DG, Lieskovsky G, et al,. The rational for en bloc pelvic lymph node dissection for bladder cancer patients with nodal metastases: long-term results. J Urol 1993; 149: 758-65 (Pubitemid 23111062)
13. Herr HW, Faulkner JR, Grossman HB, et al,. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol 2004; 22: 2781-9 (Pubitemid 41079895)
14. Dhar NB, Klein EA, Reuther AM, Thalmann GN, Madersbacher S, Studer UE,. Outcome after radical cystectomy with limited or extended pelvic lymph node dissection. J Urol 2008; 179: 873-8
15. Poulsen AL, Horn T, Steven K,. Radical cystectomy: extending the limits of pelvic lymph node dissection improves survival for patients with bladder cancer confined to the bladder wall. J Urol 1998; 160: 2015-9
16. Brossner C, Pycha A, Toth A, Mian C, Kuber W,. Does extended lymphadenectomy increase the morbidity of radical cystectomy? BJU Int 2004; 93: 64-6 (Pubitemid 38112968)
17. Hall R,. Updated results of neoadjuvant cisplatin (C), methotrexate (M) and vinblastine (V) chemotherapy for muscle-invasive bladder cancer. Proc Annu Meet Am Soc Clin Oncol 2002; 21: 178
18. Sherif A, Rintala E, Mestad O, et al,. Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer-nordic cystectomy trial 2. Scand J Urol Nephrol 2002; 36: 419-25 (Pubitemid 36169500)
19. ABCAM-a C,. Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration. Eur Urol 2005; 48: 202-5
20. Grossman H, Natale R, Tangen C, et al,. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N Eng J Med 2003; 349: 859-66 (Pubitemid 37025405)
21. David K, Milowsky MI, Ritchey J, et al,. Low incidence of perioperative chemotherapy for stage III bladder cancer 1998 to 2003: a report from the National Cancer Data Base. J Urol 2007; 178: 451-4 (Pubitemid 47030482)
22. Freiha F, Reese J, Torti FM,. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J Urol 1996; 155: 495-9
23. Stöckle M, Meyenburg W, Wellek S, et al,. Advanced bladder cancer (stages pT3b, pT4a, pN1 and pN2): improved survival after radical cystectomy and 3 adjuvant cycles of chemotherapy. J Urol 1992; 148: 302-7
24. Skinner D, Daniels J, Russell C, et al,. The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer: a prospective comparative trial. J Urol 1991; 145: 459-64
25. ABCAM-a C,. Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration. Eur Urol 2005; 48: 189-99
26. Brennan P, Bogillot O, Cordier S, et al,. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000; 86: 289-94 (Pubitemid 30180827)
27. Ferrucci L, Izmirlian G, Leveille S, et al,. Smoking, physical activity, and active life expectancy. Am J Epidemiol 1999; 149: 645-53 (Pubitemid 29162714)
28. Doll R, Peto R, Boreham J, Sutherland I,. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519
29. Mahmud SM, Fong B, Fahmy N, Tanguay S, Aprikian AG,. Effect of postoperative delay on survival in patients with bladder cancer undergoing cystectomy in Quebec: a population based study. J Urol 2006; 175: 78-83 (Pubitemid 41797090)
30. Liedberg F, Anderson H, Mansson W,. Treatment delay and prognosis in invasive bladder cancer. J Urol 2005; 174: 1777-81 (Pubitemid 41546934)
31. Chang SS, Hassan JM, Cookson MS, Wells N, Smith JA Jr,. Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage. J Urol 2003; 170: 1085-7 (Pubitemid 37108084)
32. May M, Nitzke T, Helke C, Vogler H, Hoschke B,. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. Scand J Urol Nephrol 2004; 38: 231-5 (Pubitemid 38698152)